Research

Hormonal

Polygenic scores for BMI and Type 2 Diabetes do not significantly predict weight loss outcomes in patients treated with GLP-1 receptor agonists.

If you are taking a GLP-1 RA (like semaglutide or liraglutide), your common genetic risk for obesity does not predict how much weight you will lose. The drug's effectiveness is largely independent of your polygenic score for BMI or Type 2 Diabetes. Focus on adherence and lifestyle factors rather than genetic testing for treatment selection.

GoodRefutesHIGH confidence
We found no significant associations between GLP1-RA-induced weight loss and polygenic scores for body mass index or type 2 diabetes, nor with missense variants in GLP1R.
J German et al. · Nature Medicine · 2025

Why this rating

Large multi-ancestry biobank study (n=6,750) with robust statistical power to detect small effects.

Source

Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery

J German et al. · Nature Medicine · 2025

DOI 10.1038/s41591-025-03645-3

cohort · n=10960Cited 31×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →